Glenmark Pharmaceuticals Limited has received final approval by the United States Food & Drug Administration for Clindamycin Hydrochloride Capsules USP, 75 mg, 150 mg, and 300 mg.
Eugia Pharma Specialities Ltd, subsidiary of Aurobindo Pharma Ltd has received a final approval from the USFDA to manufacture and market Lenalidomide Capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg
Alembic Pharmaceuticals Ltd today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Lenalidomide Capsules, 2.5 mg and 20 mg.
Alembic Pharmaceuticals Ltd has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.